Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.
Reilly JT. et al, (2014), Br J Haematol, 167, 418 - 420
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
Woll PS. et al, (2014), Cancer Cell, 25, 794 - 808
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
Woll PS. et al, (2014), Cancer Cell, 25, 794 - 808
10 YEARS EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINES
Khan D. et al, (2014), HAEMATOLOGICA, 99, 341 - 341
A NATIONAL EXPERIENCE OF THE USE OF PONATINIB IN PATIENTS MULTIPLE TYROSINE KINASE INHIBITORS CONFIRMS EFFICACY IN A HEAVILY PRE-TREATED COHORT OF PATIENTS WITH PH plus LEUKAEMIAS
Milojkovic D. et al, (2014), HAEMATOLOGICA, 99, 335 - 335
FLT3-ITD INDUCED MYELOPROLIFERATION CAUSES A CELL EXTRINSIC DEPLETION OF HAEMATOPOIETIC STEM CELLS
Mead AJ. et al, (2014), HAEMATOLOGICA, 99, 256 - 256
OUTCOMES FOR MYELOFIBROSIS PATIENTS WHO SWITCHED FROM FEDRATINIB TO RUXOLITINIB THERAPY
Garcia NC. et al, (2014), HAEMATOLOGICA, 99, 670 - 671
Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.
Grover A. et al, (2014), J Exp Med, 211, 181 - 188
Modification of British committee for standards in haematology diagnostic criteria for essential thrombocythaemia
Harrison CN. et al, (2014), British Journal of Haematology, 167, 421 - 423
Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012
Reilly JT. et al, (2014), British Journal of Haematology, 167, 418 - 420
Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells.
Böiers C. et al, (2013), Cell Stem Cell, 13, 535 - 548
Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy.
Sanjuan-Pla A. et al, (2013), Nature, 502, 232 - 236
Practical management of patients with myelofibrosis receiving ruxolitinib.
Harrison C. et al, (2013), Expert Rev Hematol, 6, 511 - 523
ESTABLISHMENT OF LYMPHO-MYELOID RESTRICTED PROGENITORS PRIOR TO THE EMERGENCE OF DEFINITIVE HEMATOPOIETIC STEM CELLS
Boiers C. et al, (2013), EXPERIMENTAL HEMATOLOGY, 41, S13 - S13
FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.
Mead AJ. et al, (2013), Cell Rep, 3, 1766 - 1776
A GENOMEWIDE ASSOCIATION STUDY IDENTIFIES NOVEL LOCI THAT PREDISPOSE TO MYELOPROLIFERATIVE NEOPLASMS
Jones A. et al, (2013), HAEMATOLOGICA, 98, 221 - 222
Germline counterparts of oncogenic mutations: who gives a JAK?.
Mead AJ. et al, (2013), Oncotarget, 4, 814 - 815
Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
Mead AJ. et al, (2013), Blood, 121, 4156 - 4165
MOLECULAR AND CELLULAR EFFECTS OF ONCOGENE COOPERATION IN A GENETICALLY ACCURATE AML MOUSE MODEL
Reckzeh K. et al, (2013), ANNALS OF HEMATOLOGY, 92, S1 - S2
Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia.
Eyre T. et al, (2012), Blood, 120, 4441 - 4443